Active

OBIPHAR

Switched

BE0878100418

Rechtspersoon Public limited company 1 establishment

Rue Montavaux 155, 7080 Frameries Detailhandel in farmaceutische producten

Active for

20 year, 8 months

Financials

Financial year 2025

Gross margin

€ 6,330

▼ 35% vs 2024

Profit

Caution

€ -1,220

▼ 118% vs 2024

Debts

Low

€ 100,000

OBIPHAR from Frameries, company number BE0878100418, closed financial year 2025 with a result of € -1,220 after tax. For that financial year OBIPHAR recorded a gross margin of € 6,330 and equity of € 118,848. Compared with financial year 2024, the result moved from € 6,654 to € -1,220. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What happened at OBIPHAR?

What happened at OBIPHAR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • FINPHARMA stepped down as director. NBB
  • GESTIPHARMA SA stepped down as director. NBB
  • New annual accounts for financial year 2025: loss of € 1,220 (▼ 118% vs 2024). Source: NBB ↗
  • FINPHARMA became a director. NBB
  • GESTIPHARMA SA became a director. NBB
  • New establishment in Frameries. KBO
  • Start of the company according to the CBE. KBO

In short

From € 16,581 profit in 2021 to € 1,220 loss in 2025.

Paid € 14,946 in corporate taxes since 2021.

Best year ever: 2021, with € 16,581 profit.

Paid out € 40,000 in dividends to the owners in total.

A new publication or filing at OBIPHAR? We notify you, reason included.

Follow OBIPHAR

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Directors

According to the 2025 annual accounts

FINPHARMA

Director · represented by PHILIPPE BOULANGER

Also active at: EVRAS, FELIX PHARMA

since 2023 · until 2029

GESTIPHARMA SA

Managing director · represented by PIERRE PASCAL HECQ

Also active at: Les Pharmacies Réunies, Immobilière Général Léman, P.J. VLEUGELS et Cie +17 more

since 2023 · until 2029

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Montavaux 155

7080 Frameries

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0878.100.418
VAT number
BE 0878.100.418
Registered office
Rue Montavaux 155, 7080 Frameries
Names & denominations
OBIPHAR
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
22 December 2005
Peppol
Active · Active since 1 Jan 2001
Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Frequently asked questions

What is the enterprise number of OBIPHAR?
The enterprise number of OBIPHAR is BE0878100418.
What is the address of OBIPHAR?
The registered office of OBIPHAR is located at Rue Montavaux 155, 7080 Frameries.
When was OBIPHAR founded?
OBIPHAR was founded on 22 December 2005.
What is the main activity of OBIPHAR?
The main activity of OBIPHAR is "Detailhandel in farmaceutische producten" (NACE code 47730).
Does OBIPHAR have a website?
No website is currently known for OBIPHAR.
How much profit did OBIPHAR make in 2025?
OBIPHAR recorded a loss after taxes of € 1,220 in financial year 2025.
What is the revenue of OBIPHAR?
As a small company, OBIPHAR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 6,330.
Where can I find the annual accounts of OBIPHAR?
OBIPHAR files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of OBIPHAR?
According to the 2025 annual accounts, the directors of OBIPHAR are: FINPHARMA, GESTIPHARMA SA.